SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-17-000465
Filing Date
2017-02-13
Accepted
2017-02-13 10:06:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G atra123116.htm SC 13G 52327
  Complete submission text file 0001172661-17-000465.txt   53859
Mailing Address 100 FILLMORE STREET, SUITE 325 DENVER CO 80206
Business Address 100 FILLMORE STREET, SUITE 325 DENVER CO 80206 303.398.2929
Arrowpoint Asset Management, LLC (Filed by) CIK: 0001483859 (see all company filings)

IRS No.: 392068140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88393 | Film No.: 17596508
SIC: 2836 Biological Products, (No Diagnostic Substances)